Related references
Note: Only part of the references are listed.A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Pyoderma gangrenosum associated with rheumatoid arthritis: a case report
Andre Avelino Costa Beber et al.
REVISTA BRASILEIRA DE REUMATOLOGIA (2014)
Etiology and Management of Pyoderma Gangrenosum A Comprehensive Review
Iris Ahronowitz et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)
Tocilizumab for Rheumatoid Arthritis: A Cochrane Systematic Review
Jasvinder A. Singh et al.
JOURNAL OF RHEUMATOLOGY (2011)
Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
Laura Campbell et al.
RHEUMATOLOGY (2011)
Share Paper
